Abiomed AB5000 Circulatory Support System Recall: Risk of Injury or Death

A Class 1 medical device recall has been issued for Abiomed, Inc.’s AB5000 Circulatory Support System after it was determined that the device, which keeps the heart pumping in cases of heart failure, can suddenly stop operating without warning.

The FDA sent out an AB5000 Circulatory Support System recall notice this week, after Abiomed sent letters to customers alerting them of the problem last month.

The computer in the device can shut down, and the system can stop pumping a patient’s heart without warning, according to the FDA statement. Although there have been no injuries reported in connection to the defective circulatory support systems, the action has been classified as a Class 1 recall because of the risk of serious injury or death.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

Abiomed circulatory support systems are used to keep the right, left, or both sides of a patient’s heart pumping after heart failure temporarily until the natural heart rhythm can be restored. The device itself is linked to a portable computer console which allows the patient mobility.

The recall affects the Abiomed AB5000 Circulatory Support System, catalog number 0015-0000, with serial numbers AD5001 through AD5496. Systems with serial numbers AD5006 and AD5018 are exempt from the recall. The systems were manufactured and sold from May 2003 through December 2009 by the Massachusetts-based company.

The company contacted customers via letter on January 27, 2010. The FDA requests that any health care professionals or patients who experience an adverse medical event or reaction while using this device contact FDA’s Medwatch Adverse Event Reporting Program at http://www.fda.gov/medwatch.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic and Rybelsus Side Effects Led to Ileus, Nausea and Vomiting, Lawsuit Alleges
Ozempic and Rybelsus Side Effects Led to Ileus, Nausea and Vomiting, Lawsuit Alleges (Posted yesterday)

A Kentucky man's lawsuit claims Ozempic and Rybelsus side effects led to multiple trips to the emergency room due to nausea, vomiting and other reactions to his intestinal muscles being unable to push food through his digestive tract.

Multi-Day Suboxone Lawsuit Status Conference Being Held To Review Census Protocol and Procedures
Multi-Day Suboxone Lawsuit Status Conference Being Held To Review Census Protocol and Procedures (Posted yesterday)

Lawyers will be meeting with the MDL judge presiding over all Suboxone tooth decay lawsuits on October 4 and 5, 2024, to finalize information needed to select a group of representative cases for bellwether discovery and trial.

Bard Settlement Reached To Resolve Hernia Mesh Lawsuits, With “Multi-Year” Payout Structure
Bard Settlement Reached To Resolve Hernia Mesh Lawsuits, With “Multi-Year” Payout Structure (Posted 2 days ago)

Lawyers have reached a confidential settlement agreement to resolve tens of thousands of Bard hernia mesh lawsuits after six years of litigation, but individuals must still agree to participate and settle their claims.